• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

光学组织测量浸润性癌和导管原位癌以指导手术。

Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.

机构信息

Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Postbus 90203, 1006, Amsterdam, BE, Netherlands.

Department of Pathology, Ghent University Hospital, and Cancer Research Institute Ghent (CRIG), Ghent University, Ghent, Belgium.

出版信息

Breast Cancer Res. 2021 May 22;23(1):59. doi: 10.1186/s13058-021-01436-5.

DOI:10.1186/s13058-021-01436-5
PMID:34022928
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8141169/
Abstract

BACKGROUND

Although the incidence of positive resection margins in breast-conserving surgery has decreased, both incomplete resection and unnecessary large resections still occur. This is especially the case in the surgical treatment of ductal carcinoma in situ (DCIS). Diffuse reflectance spectroscopy (DRS), an optical technology based on light tissue interactions, can potentially characterize tissue during surgery thereby guiding the surgeon intraoperatively. DRS has shown to be able to discriminate pure healthy breast tissue from pure invasive carcinoma (IC) but limited research has been done on (1) the actual optical characteristics of DCIS and (2) the ability of DRS to characterize measurements that are a mixture of tissue types.

METHODS

In this study, DRS spectra were acquired from 107 breast specimens from 107 patients with proven IC and/or DCIS (1488 measurement locations). With a generalized estimating equation model, the differences between the DRS spectra of locations with DCIS and IC and only healthy tissue were compared to see if there were significant differences between these spectra. Subsequently, different classification models were developed to be able to predict if the DRS spectrum of a measurement location represented a measurement location with "healthy" or "malignant" tissue. In the development and testing of the models, different definitions for "healthy" and "malignant" were used. This allowed varying the level of homogeneity in the train and test data.

RESULTS

It was found that the optical characteristics of IC and DCIS were similar. Regarding the classification of tissue with a mixture of tissue types, it was found that using mixed measurement locations in the development of the classification models did not tremendously improve the accuracy of the classification of other measurement locations with a mixture of tissue types. The evaluated classification models were able to classify measurement locations with > 5% malignant cells with a Matthews correlation coefficient of 0.41 or 0.40. Some models showed better sensitivity whereas others had better specificity.

CONCLUSION

The results suggest that DRS has the potential to detect malignant tissue, including DCIS, in healthy breast tissue and could thus be helpful for surgical guidance.

摘要

背景

尽管保乳手术中的阳性切缘发生率有所下降,但仍存在不完全切除和不必要的大范围切除的情况。这在导管原位癌(DCIS)的手术治疗中尤为明显。基于光与组织相互作用的漫反射光谱(DRS)技术,在手术过程中有可能对组织进行特征描述,从而为外科医生提供术中指导。DRS 已被证明能够区分纯健康的乳腺组织和纯浸润性癌(IC),但对(1)DCIS 的实际光学特性和(2)DRS 对组织类型混合物进行特征描述的能力的研究有限。

方法

本研究共采集了 107 例经证实患有 IC 和/或 DCIS(1488 个测量部位)的 107 例患者的 107 个乳腺标本的 DRS 光谱。通过广义估计方程模型,比较了 DCIS 与 IC 和仅健康组织的部位的 DRS 光谱之间的差异,以确定这些光谱之间是否存在显著差异。随后,开发了不同的分类模型,以能够预测测量部位的 DRS 光谱是否代表“健康”或“恶性”组织。在模型的开发和测试中,对“健康”和“恶性”采用了不同的定义。这使得训练和测试数据的同质性水平可以发生变化。

结果

发现 IC 和 DCIS 的光学特性相似。关于组织类型混合物的分类,发现在开发分类模型时使用混合测量部位并不会极大地提高对组织类型混合物的其他测量部位的分类准确性。评估的分类模型能够以 0.41 或 0.40 的马修斯相关系数对>5%恶性细胞的测量部位进行分类。一些模型具有更好的敏感性,而其他模型具有更好的特异性。

结论

结果表明,DRS 有可能在健康的乳腺组织中检测到包括 DCIS 在内的恶性组织,因此可能有助于手术指导。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/7db18f8596a7/13058_2021_1436_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/741c359d23c8/13058_2021_1436_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/e46903738092/13058_2021_1436_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/48ba8249d08b/13058_2021_1436_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/0cf83ef091fd/13058_2021_1436_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/fe2e84d87e12/13058_2021_1436_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/7db18f8596a7/13058_2021_1436_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/741c359d23c8/13058_2021_1436_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/e46903738092/13058_2021_1436_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/48ba8249d08b/13058_2021_1436_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/0cf83ef091fd/13058_2021_1436_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/fe2e84d87e12/13058_2021_1436_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a93e/8141169/7db18f8596a7/13058_2021_1436_Fig6_HTML.jpg

相似文献

1
Optical tissue measurements of invasive carcinoma and ductal carcinoma in situ for surgical guidance.光学组织测量浸润性癌和导管原位癌以指导手术。
Breast Cancer Res. 2021 May 22;23(1):59. doi: 10.1186/s13058-021-01436-5.
2
Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.导线引导下保乳手术后导管原位癌与浸润性乳腺癌的再次手术率
JAMA Surg. 2017 Apr 1;152(4):378-384. doi: 10.1001/jamasurg.2016.4751.
3
Ductal carcinoma in situ in core biopsies containing invasive breast cancer: correlation with extensive intraductal component and lumpectomy margins.包含浸润性乳腺癌的粗针活检中的导管原位癌:与广泛导管内成分及肿块切除切缘的相关性
J Surg Oncol. 2005 May 1;90(2):71-6. doi: 10.1002/jso.20242.
4
Does intraductal breast cancer spread in a segmental distribution? An analysis of residual tumour burden following segmental mastectomy using tumour bed biopsies.导管内乳腺癌是否呈节段性扩散?一项使用瘤床活检对节段性乳房切除术后残余肿瘤负荷的分析。
Eur J Surg Oncol. 2001 Feb;27(1):21-5. doi: 10.1053/ejso.2000.1051.
5
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.
6
The radiological excision of high risk and malignant lesions using the INTACT breast lesion excision system. A case series with an imaging follow up of at least 5 years.使用 INTACT 乳房病变切除系统切除高危和恶性病变的放射学切除。至少进行了 5 年影像学随访的病例系列。
Eur J Surg Oncol. 2014 Jul;40(7):824-9. doi: 10.1016/j.ejso.2014.03.022. Epub 2014 Apr 2.
7
Location and extent of positive resection margins and ductal carcinoma in situ in lumpectomy specimens of ductal breast carcinoma examined with a microscopic three-dimensional view.采用显微三维视图检查的乳腺导管癌肿块切除标本中,阳性切缘及导管原位癌的位置和范围。
Breast J. 2003 Jan-Feb;9(1):33-8. doi: 10.1046/j.1524-4741.2003.09108.x.
8
Extent of ductal carcinoma in situ according to breast cancer subtypes: a population-based cohort study.根据乳腺癌亚型分析导管原位癌的范围:一项基于人群的队列研究。
Breast Cancer Res Treat. 2016 Jul;158(1):179-187. doi: 10.1007/s10549-016-3862-4. Epub 2016 Jun 18.
9
Magnetic resonance imaging system for intraoperative margin assessment for DCIS and invasive breast cancer using the ClearSight™ system in breast-conserving surgery-Results from a postmarketing study.应用 ClearSight™系统的磁共振成像系统在保乳手术中用于 DCIS 和浸润性乳腺癌的术中切缘评估-来自上市后研究的结果。
J Surg Oncol. 2022 Mar;125(3):361-368. doi: 10.1002/jso.26721. Epub 2021 Nov 1.
10
Positive surgical margins after breast-conserving surgery for ductal carcinoma in-situ: does histologic grade or estrogen receptor status matter?保乳手术后导管原位癌的阳性切缘:组织学分级或雌激素受体状态重要吗?
Breast Cancer Res Treat. 2023 Jun;199(2):215-220. doi: 10.1007/s10549-023-06905-3. Epub 2023 Apr 7.

引用本文的文献

1
Diffuse reflectance and fluorescence spectroscopy for breast conserving surgery.用于保乳手术的漫反射和荧光光谱学
Breast Cancer Res Treat. 2025 Nov;214(1):25-36. doi: 10.1007/s10549-025-07790-8. Epub 2025 Aug 1.
2
Real-time peri-operative microcalcification detection in superficial breast tissues.浅表乳腺组织围手术期微钙化的实时检测
Sci Rep. 2025 May 16;15(1):17029. doi: 10.1038/s41598-025-01629-4.
3
Tissue-probe contact assessment during robotic surgery using single-fiber reflectance spectroscopy.使用单纤维反射光谱法在机器人手术期间进行组织-探头接触评估。

本文引用的文献

1
No Ink on Ductal Carcinoma : A Single Centre Experience.导管癌无墨水染色:单中心经验
Anticancer Res. 2019 Jan;39(1):459-466. doi: 10.21873/anticanres.13134.
2
Towards the use of diffuse reflectance spectroscopy for real-time in vivo detection of breast cancer during surgery.针对在手术期间实时体内检测乳腺癌中使用漫反射光谱技术的研究。
J Transl Med. 2018 Dec 19;16(1):367. doi: 10.1186/s12967-018-1747-5.
3
Does intra-operative margin assessment improve margin status and re-excision rates? A population-based analysis of outcomes in breast-conserving surgery for ductal carcinoma in situ.
Biomed Opt Express. 2024 Nov 11;15(12):6756-6767. doi: 10.1364/BOE.534558. eCollection 2024 Dec 1.
4
Feasibility of Diffuse Reflection Spectroscopy for Intraoperative Margin Assessment During Prostatectomy.弥漫反射光谱法在前列腺切除术中进行术中切缘评估的可行性
Eur Urol Open Sci. 2024 Aug 10;67:62-68. doi: 10.1016/j.euros.2024.07.112. eCollection 2024 Sep.
5
Margin assessment during breast conserving surgery using diffuse reflectance spectroscopy.应用漫反射光谱技术评估保乳手术中的切缘。
J Biomed Opt. 2024 Apr;29(4):045006. doi: 10.1117/1.JBO.29.4.045006. Epub 2024 Apr 25.
6
Optical Emission Spectroscopy for the Real-Time Identification of Malignant Breast Tissue.用于实时识别恶性乳腺组织的光发射光谱学
Diagnostics (Basel). 2024 Feb 4;14(3):338. doi: 10.3390/diagnostics14030338.
7
Diffuse reflectance spectroscopy for accurate margin assessment in breast-conserving surgeries: importance of an optimal number of fibers.用于保乳手术中准确切缘评估的漫反射光谱法:最佳光纤数量的重要性。
Biomed Opt Express. 2023 Jul 10;14(8):4017-4036. doi: 10.1364/BOE.493179. eCollection 2023 Aug 1.
8
Functional Imaging of Hypoxia: PET and MRI.缺氧的功能成像:正电子发射断层扫描(PET)和磁共振成像(MRI)
Cancers (Basel). 2023 Jun 25;15(13):3336. doi: 10.3390/cancers15133336.
术中切缘评估能否改善切缘状态及再次切除率?一项基于人群的导管原位癌保乳手术结局分析。
J Surg Oncol. 2018 Dec;118(7):1205-1211. doi: 10.1002/jso.25248. Epub 2018 Oct 7.
4
Tumor Resection Margin Definitions in Breast-Conserving Surgery: Systematic Review and Meta-analysis of the Current Literature.保乳手术中肿瘤切缘定义:当前文献的系统回顾和荟萃分析。
Clin Breast Cancer. 2018 Aug;18(4):e595-e600. doi: 10.1016/j.clbc.2018.04.004. Epub 2018 Apr 13.
5
Breast-specific factors determine cosmetic outcome and patient satisfaction after breast-conserving therapy: Results from the randomized COBALT study.保乳治疗后,乳房特异性因素决定美容效果和患者满意度:随机COBALT研究结果
J Surg Oncol. 2018 Apr;117(5):1001-1008. doi: 10.1002/jso.25012. Epub 2018 Feb 23.
6
Factors Associated With Positive Margins in Women Undergoing Breast Conservation Surgery.与行保乳手术的女性切缘阳性相关的因素。
Mayo Clin Proc. 2018 Apr;93(4):429-435. doi: 10.1016/j.mayocp.2017.11.023. Epub 2018 Feb 10.
7
Margins in breast cancer: How much is enough?乳腺癌的切缘:多少才算足够?
Cancer. 2018 Apr 1;124(7):1335-1341. doi: 10.1002/cncr.31221. Epub 2018 Jan 16.
8
Margin width and local recurrence after breast conserving surgery for ductal carcinoma in situ.导管原位癌保乳手术后的切缘宽度与局部复发
Eur J Surg Oncol. 2017 Nov;43(11):2029-2035. doi: 10.1016/j.ejso.2017.08.003. Epub 2017 Sep 4.
9
Changes in margin re-excision rates: Experience incorporating the "no ink on tumor" guideline into practice.切缘再次切除率的变化:将“肿瘤无墨水”指南纳入实践的经验
J Surg Oncol. 2017 Dec;116(8):1040-1045. doi: 10.1002/jso.24770. Epub 2017 Jul 27.
10
Ductal Carcinoma In Situ and Margins <2 mm: Contemporary Outcomes With Breast Conservation.导管原位癌和切缘<2mm:保乳治疗的当代结果。
Ann Surg. 2019 Jan;269(1):150-157. doi: 10.1097/SLA.0000000000002439.